Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscopic improvement versus placebo
Updated ANTHEM-UC data support Phase 3 clinical development of icotrokinra in both moderately to severely active ulcerative colitis and Crohn's disease
In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ICONIC-TOTAL study
Further, 67% of patients treated with icotrokinra in the ICONIC-TOTAL study achieved overall rates of clear or almost clear skin by Week 24, which was maintained through Week 52
Read MoreAdvancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration
Read More
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
Read MoreNew findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.
Read More
OI Suite Discovery Program launches with complimentary access for researchers in biopharma companies and academic centers to accelerate biomarker discovery through an intuitive, no-code interface.
CanvOI, running on Oracle Cloud Infrastructure (OCI), is now trained on more than 1.5 million biopsy images across 40+ organs and designed to perform in small early-phase cohorts.
Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution.
Read MoreFindings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways.
Read MoreStrong consumer demand and rapid market adoption drive CBDL's beverage expansion as top-selling CBD Lemonade, Raspberry Lemonade, and Lavender Lemonade hit the shelves of Smoking Scholars in New York City - setting the stage for record-breaking revenue in Q4 and beyond.
Read More
Highlighting the Solutions Transforming Data Accuracy, Automation, and AI-Driven Revenue Integrity at the Minneapolis Convention Center, October 12–14, 2025
Read More